TriCleanse™

Placental ECM Process

A proprietary processing method that balances thorough decellularization of tissues while preserving the structure and functionality of the placental extracellular matrix (ECM)

About the TriCleanse™  Process

A Delicate Balance

The TriCleanse™ Process effectively removes cells and cellular debris while maintaining the structural proteins of the ECM1.

A Delicate Balance graphic

The Power of Decellularization

The proper decellularization of ECMs is critical to the function of the final ECM product. The goal of decellularization is to remove the cells and eliminate residual genetic material, while preserving the ECM components and retaining the properties of the base tissue1. Incomplete decellularization has been shown to decrease the ratio of M2-activated macrophages to M1-macrophages when compared to more complete decellularization methods2. Further studies have demonstrated that higher ratios of M2-activated to M1-activated macrophages are more promotive of immunomodulation, constructive mechanisms, and remodeling activities3.

Watch the effects of extracellular matrix on a stalled wound and the importance of thoroughly decellularizing the ECM.

Decellularization Efficiency of the TriCleanse™ Process

Placental devices manufactured utilizing the TriCleanse™ Process were compared to raw untreated placentas to determine the decellularization efficiency of the process. Histologic evaluations were performed to assess the impact of processing on placental tissue. These comparisons confirm that the TriCleanse™ Process successfully removes the cellular component of the placenta while leaving the structural and modulating proteins intact in the final product4,5. This is the goal of efficient decellularization.

Cell and Cellular Debris Removal5

Figures on the left are untreated placentas and clearly show that the placenta is highly cellularized prior to processing. Figures on the right show placentas that have been treated with the TriCleanse™ Process; the treated placenta appears thoroughly decellularized and nearly void of any intact nuclei5.

DAPI (4′, 6-diamidino-2-phenylindole) Staining

DAPI staining is a fluorescent DNA stain with high affinity for the AT region of double stranded DNA in either fixed or live cells6. DAPI has been demonstrated to efficiently label cell nuclei for easier quantification7.

Hematoxylin & Eosin Staining 

Hematoxylin and eosin (H&E) staining is commonly used to stain tissue for histology evaluation8. H&E stains nuclei blue and ECM and cytoplasm pink and other tissues shades in between.

Preservation of the ECM5

These images demonstrate that Collagen I, Collagen III, and Laminin are present in the placenta prior to processing and remain in the tissues after processing. This is an indicator that the TriCleanse™ process preserves the structural proteins of the ECM.

Figures on the left show untreated placentas, and figures on the right show placentas treated with the TriCleanse™ Process.

Herovici Staining

Herovici staining is a technique that utilizes two separate preferential chromatic stains and image processing to calculate the ratio of Collagen Type III to Collagen Type I.

Laminin Immunostaining 

Immunostaining is a technique that allows for detection of specific proteins in the tissue. The staining allows for determination of presence and location of the protein. This particular stain was for laminin, a protein that is the major component of basement membranes.

Maintaining High Standards

Our production facility was specifically designed to meet the rigorous ISO 13485 standards, including ISO Class 7 clean rooms, and the facility is staffed with highly trained technicians. This ensures that each product not only meets regulatory requirements but also maintains the highest standards of safety and quality.

MKT-2023-0051-05E V01

References:

    1. Gilpin A, Yang Y. Decellularization Strategies for Regenerative Medicine: From Processing Techniques to Applications. Biomed Res Int. 2017;2017:9831534. doi: 10.1155/2017/9831534. Epub 2017 Apr 30. PMID: 28540307; PMCID: PMC5429943
    2. Keane, T. J., Londono, R., Turner, N. J., & Badylak, S. F. (2012). Consequences of ineffective decellularization of biologic scaffolds on the host response. Biomaterials, 33(6), 1771- 1781. doi:10.1016/j.biomaterials.2011.10.054
    3. Sicari, B. M., Dziki, J. L., Siu, B. F., Medberry, C. J., Dearth, C. L., & Badylak, S. F. (2014). The promotion of a constructive macrophage phenotype by solubilized extracellular matrix. Biomaterials, 35(30), 8605-8612. doi:10.1016/j. biomaterials.2014.06.060
    4. K193552 510(k) Summary
    5. Data on file -RDR-002
    6. Chazotte, B. (2011). Labeling nuclear DNA using DAPI. Cold Spring Harb Protoc, 2011(1), pdb prot5556. doi:10.1101/pdb .prot5556
    7. Lau, Y. S., Xu, L., Gao, Y., & Han, R. (2018). Automated muscle histopathology analysis using CellProfiler. Skelet Muscle, 8(1), 32. doi:10.1186/s13395-018-0178-6
    8. Hinton, J. P., Dvorak, K., Roberts, E., French, W. J., Grubbs, J. C., Cress, A. E., . . . Nagle, R. B. (2019). A Method to Reuse Archived H&E Stained Histology Slides for a Multiplex Protein Biomarker Analysis. Methods Protoc, 2(4). doi:10.3390/mps2040086